Vitrolife's year end report for 2003 will be presented the 17th of February instead of the earlier date preliminary set

Vitrolife's year end report for 2003 will be presented the 17th of February instead of the earlier date preliminary set (12th February) due to a change of date of board meeting. Magnus Nilsson President & CEO, Vitrolife AB ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2004/02/02/20040202BIT00980/wkr0001.doc http://www.waymaker.net/bitonline/2004/02/02/20040202BIT00980/wkr0002.pdf

About Us

Vitrolife is an international medical device Group. The Fertility product area develops, produces and markets medical devices for assisted reproduction. Work is also carried out to enable the use and handling of stem cells for therapeutic purposes. Vitrolife has approximately 330 employees and the company’s products are sold in about 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in USA, Australia, France, Italy, United Kingdom, China, Japan, Hungary and Denmark. The Vitrolife share is listed on NASDAQ OMX Stockholm, Mid Cap.

Subscribe